alexa Management Of Hair Loss
ISSN: 2155-9554

Journal of Clinical & Experimental Dermatology Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

6th International Conference on Cosmetology, Trichology and Aesthetic Practices
April 13-14, 2017 Dubai, UAE

Pragya Nair P
Pramukhswami Medical College, India
Posters & Accepted Abstracts: J Clin Exp Dermatol Res
DOI: 10.4172/2155-9554.C1.054
Abstract
Loss of hair is one of the commonest complaints that baffle dermatologists. Depending on whether hair follicles are permanently damaged or not, hair loss from the scalp is divided into scarring and non-scarring alopecia’s. Causes of non-scarring alopecia includes congenital and hereditary disorders, telogen and anagen hair loss, hair shaft defects, alopecia totals and universalis, telogen effluvium, andogenic alopecia, alopecia areata, drugs or any systemic illness. Discoid lupus erythematous, morphea, trauma and pseudopalade of brocq are few of the causes of cicatricial alopecia. Hair evaluation methods are grouped into three main categories: Non-invasive methods (e.g., questionnaire, daily hair counts, standardized wash test, 60-s hair count, global photographs, dermoscopy, hair weight, phototrichogram, trichoScan and polarizing and surface electron microscopy), semi-invasive method involves trichogram and invasive method includes scalp biopsy. Complete blood count and routine urine examination, levels of serum ferritin and T3, T4 and TSH should be checked in all cases of diffuse hair loss. High fever, any infection or disease should be identified and treated. Patients with suspected excess androgen need hormonal assessment. Telogen effluvium does not require specific drugs as the condition is self-limiting and usually resolves in 3-6 months. Oral iron sulphate, zinc and biotin should be given in deficient cases. Drugs should be avoided which are causing hair loss. Minoxidil solution 2% and 5% is indicated for mild to moderate hair loss while Minoxidil 2% plus antiandrogens/ finestride for hair loss with hyperandrogenism. Hair prosthesis (wig, hair extension, hairpiece) and hair cosmetics (tinted powders, lotions sprays) is used for severe and recalcitrant hair loss and also as an adjuvant to medical therapy in mild to moderate cases. Ideal candidate for hair transplantation are those who have high-density donor hair (>40 follicular unit/cm2). Other therapies like PRP (Platelet Rich Plasma) and meso therapy have also been used with good results.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords